Economic aspects of a general vaccination against invasive disease caused by Haemophilus influenzae type b (Hib) via the experience of the Children's Hospital La Fe, Valencia, Spain
- 31 December 1995
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 13 (16), 1563-1566
- https://doi.org/10.1016/0264-410x(95)00087-h
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cost-benefit Analysis of General Vaccination against Haemophilus influenzae type b in SwedenScandinavian Journal of Infectious Diseases, 1994
- Epidemiology of invasive Haemophilus influenzae type b (Hib) disease in IsraelVaccine, 1993
- National follow up of Haemophilus influenzae meningitis.Archives of Disease in Childhood, 1993
- Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccinesThe Pediatric Infectious Disease Journal, 1993
- Comparison of the epidemiology and cost of Haemophilus influenzae type b disease in five western countriesThe Pediatric Infectious Disease Journal, 1993
- Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccinesThe Lancet, 1992
- Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule.Archives of Disease in Childhood, 1992
- Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infantsThe Pediatric Infectious Disease Journal, 1991
- Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61 080 childrenThe Pediatric Infectious Disease Journal, 1991
- A population-based retrospective assessment of the disease burden resulting from invasive Haemophilus influenzae in infants and young children in Santiago, ChileThe Pediatric Infectious Disease Journal, 1990